TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T09548 XX ID T09548 XX DT 31.10.2006 (created); smt. DT 08.10.2014 (updated); spk. CO Copyright (C), QIAGEN. XX FA IRF-3 XX SY Interferon Regulatory Factor 3; IRF-3; IRF3. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002598 IRF3; HGNC: IRF3. XX CL C0022; trp. XX SZ 427 AA; 47.2 kDa (cDNA) (calc.). XX SQ MGTPKPRILPWLVSQLDLGQLEGVAWVNKSRTRFRIPWKHGLRQDAQQEDFGIFQAWAEA SQ TGAYVPGRDKPDLPTWKRNFRSALNRKEGLRLAEDRSKDPHDPHKIYEFVNSGVGDFSQP SQ DTSPDTNGGGSTSDTQEDILDELLGNMVLAPLPDPGPPSLAVAPEPCPQPLRSPSLDNPT SQ PFPNLGPSENPLKRLLVPGEEWEFEVTAFYRGRQVFQQTISCPEGLRLVGSEVGDRTLPG SQ WPVTLPDPGMSLTDRGVMSYVRHVLSCLGGGLALWRAGQWLWAQRLGHCHTYWAVSEELL SQ PNSGHGPDGEVPKDKEGGVFDLGPFIVDLITFTEGSGRSPRYALWFCVGESWPQDQPWTK SQ RLVMVKVVPTCLRALVEMARVGGASSLENTVDLHISNSHPLSLTSDQYKAYLQDLVEGMD SQ FQGPGES XX SC translated from EMBL #Z56281 XX FT 1 112 SM00348; IRF. FT 7 112 PF00605; Interferon regulatory factor transcription f. FT 198 375 IAD, IRF association domain [2]. XX IN T23264 IRF-3a; human, Homo sapiens. IN T23266 IRF-3c; human, Homo sapiens. IN T17876 RORgamma; Mammalia. XX MX M01279 V$IRF3_Q3. MX M08887 V$IRF_Q4. MX M00772 V$IRF_Q6. MX M00972 V$IRF_Q6_01. XX BS R10351. BS R10352. BS R10353. BS R10354. BS R10355. BS R10356. BS R10357. BS R10358. BS R10359. BS R10360. BS R10361. BS R10362. BS R10363. BS R10364. BS R10365. BS R10366. BS R12440. BS R14452. BS R14454. BS R19557. BS R19558. BS R14802. BS R14440. BS R34309. XX DR TRANSPATH: MO000089915. DR EMBL: U86636; DR EMBL: Z56281; DR UniProtKB: Q14653; XX RN [1]; RE0016765. RX PUBMED: 10938111. RA Lin R., Genin P., Mamane Y., Hiscott J. RT Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7 RL Mol. Cell. Biol. 20:6342-6353 (2000). RN [2]; RE0017830. RX PUBMED: 10586038. RA Meraro D., Hashmueli S., Koren B., Azriel A., Oumard A., Kirchhoff S., Hauser H., Nagulapalli S., Atchison M. L., Levi B.- Z. RT Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. RL J. Immunol. 163:6468-6478 (1999). RN [3]; RE0024013. RX PUBMED: 9660935. RA Wathelet M. G., Lin C. H., Parekh B. S., Ronco L. V., Howley P. M., Maniatis T. RT Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. RL Mol. Cell 1:507-518 (1998). RN [4]; RE0024081. RX PUBMED: 12473110. RA Yang H., Lin C. H., Ma G., Orr M., Baffi M. O., Wathelet M. G. RT Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. RL Eur. J. Biochem. 269:6142-6151 (2002). RN [5]; RE0051557. RX PUBMED: 15361868. RA Kawai T., Sato S., Ishii K. J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J., Uematsu S., Takeuchi O., Akira S. RT Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. RL Nat. Immunol. 5:1061-1068 (2004). RN [6]; RE0055115. RX PUBMED: 15661910. RA Saitoh T., Yamamoto M., Miyagishi M., Taira K., Nakanishi M., Fujita T., Akira S., Yamamoto N., Yamaoka S. RT A20 is a negative regulator of IFN regulatory factor 3 signaling. RL J. Immunol. 174:1507-1512 (2005). RN [7]; RE0068561. RX PUBMED: 16116171. RA Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y. M., Gale M J. r., Akira S., Yonehara S., Kato A., Fujita T. RT Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. RL J. Immunol. 175:2851-2858 (2005). RN [8]; RE0070756. RX PUBMED: 20406818. RA Nistal-Villan E., Gack M. U., Martinez-Delgado G., Maharaj N. P., Inn K. S., Yang H., Wang R., Aggarwal A. K., Jung J. U., Garcia-Sastre A. RT Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. RL J. Biol. Chem. 285:20252-20261 (2010). XX //